Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Pregnant patients with vs without connective tissue diseases faced increased risks for adverse maternal and fetal outcomes, including maternal death, preterm labor, and hypertensive disorders.

Anti-inflammatory medications are a cornerstone of treatment for mixed connective tissue disease (MCTD) but your diet also is important. Eating foods that suppress inflammation may help prevent ...

Background: Connective tissue disorders (CTDs) are a heterogeneous group of ... myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), SH, gastroesophageal reflux disease (GERD), hypothyroidism, ...

Wearable devices are associated with a reduced risk for major adverse cardiovascular events and all-cause mortality in patients with ischemic heart disease. However, evidence of their effects on ...

“The point of our work — what we all do — is relieving suffering caused by disease,” said co-senior author Sabina Berretta, HMS associate professor of psychiatry at McLean Hospital and director of the ...

The American Cancer Society's estimates for soft tissue sarcomas in the United States for 2025 are: About 13,520 new soft tissue sarcomas will be diagnosed (7,600 in males and 5920 in females). About ...